wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q43061578-B87E4142-FC72-4674-890C-AC5D3EC9ADC2
Q43061578-B87E4142-FC72-4674-890C-AC5D3EC9ADC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43061578-B87E4142-FC72-4674-890C-AC5D3EC9ADC2
Natalizumab: a promising treatment for Crohn's disease.
P2860
Q43061578-B87E4142-FC72-4674-890C-AC5D3EC9ADC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43061578-B87E4142-FC72-4674-890C-AC5D3EC9ADC2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
60655674173a48ef456dcceaf8b1a0fa584017e6
P2860
A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis.